Want to join the conversation?
$PHM, which competes with $KBH, $LEN and $DHI, said it is on track with its prior guidance of investing approx. $1.2Bil, excluding Wieland, for land acquisition in 2016. The company added this estimate assumes that it continue to identify projects that meet its disciplined underwriting guideline and return thresholds.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.